Clinical Trial Update: Prognostic Value of (DHODH) Expression in (HGSOC): A Comparative Study Between Neoadjuvant and Adjuvant Chemotherapy Settings

View source ↗

Summary

This clinical trial explores whether DHODH expression serves as a prognostic biomarker in high-grade serous ovarian cancer and compares its relevance in neoadju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer

Snippet

Sponsor: Heba Ahmed Mohamed | Conditions: HGSOC | Status: NOT_YET_RECRUITING